Atossa Therapeutics, Inc. ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company focused on transforming breast cancer treatment and prevention, announced the completion of a Type C ...
A new study identifies a biological process that empowers specific brain cells to eliminate harmful proteins associated with ...
PsyPost on MSN
Alzheimer’s drug Lecanemab works by triggering a specific cleaning program in immune cells
New research provides evidence that the Alzheimer’s disease drug Lecanemab functions by activating a specific cleaning ...
Onctura, a clinical-stage biopharmaceutical company combating neglected and hard-to-treat cancers, today announces it has dosed the first patient in its Phase I/II clinical trial evaluating ...
Oncotelic Therapeutics, Inc. (OTCQB: OTLC) 45% owned Joint Venture, Sapu Nano today announced new biomarker data identifying a molecular signature that predicts sensitivity to Sapu003, the company’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback